IL165269A0 - Use of quinoline derivatives with anti-integrase effect and applications thereof - Google Patents

Use of quinoline derivatives with anti-integrase effect and applications thereof

Info

Publication number
IL165269A0
IL165269A0 IL16526903A IL16526903A IL165269A0 IL 165269 A0 IL165269 A0 IL 165269A0 IL 16526903 A IL16526903 A IL 16526903A IL 16526903 A IL16526903 A IL 16526903A IL 165269 A0 IL165269 A0 IL 165269A0
Authority
IL
Israel
Prior art keywords
applications
quinoline derivatives
integrase
effect
integrase effect
Prior art date
Application number
IL16526903A
Other languages
English (en)
Original Assignee
Univ Paris Sud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Sud filed Critical Univ Paris Sud
Publication of IL165269A0 publication Critical patent/IL165269A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
IL16526903A 2002-05-17 2003-05-15 Use of quinoline derivatives with anti-integrase effect and applications thereof IL165269A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0206126A FR2839646B1 (fr) 2002-05-17 2002-05-17 Utilisation de derives de quinoleine a effet anti-integrase et ses applications
PCT/FR2003/001487 WO2003096965A2 (fr) 2002-05-17 2003-05-15 Derives de quinoleine a effet anti-integrase et leurs applications comme antiviraux

Publications (1)

Publication Number Publication Date
IL165269A0 true IL165269A0 (en) 2005-12-18

Family

ID=29286592

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16526903A IL165269A0 (en) 2002-05-17 2003-05-15 Use of quinoline derivatives with anti-integrase effect and applications thereof

Country Status (8)

Country Link
US (2) US7479497B2 (ja)
EP (1) EP1507532A2 (ja)
JP (1) JP2005531554A (ja)
AU (1) AU2003251047A1 (ja)
CA (1) CA2489102A1 (ja)
FR (1) FR2839646B1 (ja)
IL (1) IL165269A0 (ja)
WO (1) WO2003096965A2 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080280849A1 (en) * 2005-06-01 2008-11-13 Herve Leh Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents
JP5269086B2 (ja) * 2007-11-15 2013-08-21 ギリアード サイエンシス インコーポレーテッド ヒト免疫不全ウイルスの複製阻害薬
US7956068B2 (en) * 2007-11-15 2011-06-07 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
WO2009062285A1 (en) * 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
WO2009062308A1 (en) * 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
JP5984218B2 (ja) 2010-07-02 2016-09-06 ギリアード サイエンシーズ， インコーポレイテッド Ａｉｄｓを処置するためのナフト−２−イル酢酸誘導体
WO2012003498A1 (en) * 2010-07-02 2012-01-05 Gilead Sciences, Inc. 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
KR20140027295A (ko) 2011-04-21 2014-03-06 길리애드 사이언시즈, 인코포레이티드 벤조티아졸 화합물 및 이들의 약학적 용도
SI2691530T1 (en) 2011-06-10 2018-08-31 Oregon Health & Science University CMV glycoproteins and recombinant vectors
CA2856722C (en) 2011-11-30 2022-11-22 Emory University Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
WO2013103724A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
PE20141558A1 (es) 2012-04-20 2014-11-06 Gilead Sciences Inc Derivados de acido benzotiazol-6-il acetico y su uso para tratar una infeccion por vih

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761687B1 (fr) * 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
FR2830863B1 (fr) * 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives

Also Published As

Publication number Publication date
US20080161350A1 (en) 2008-07-03
WO2003096965A2 (fr) 2003-11-27
US20050261336A1 (en) 2005-11-24
FR2839646B1 (fr) 2008-04-11
EP1507532A2 (fr) 2005-02-23
FR2839646A1 (fr) 2003-11-21
AU2003251047A8 (en) 2003-12-02
US7479497B2 (en) 2009-01-20
JP2005531554A (ja) 2005-10-20
CA2489102A1 (fr) 2003-11-27
AU2003251047A1 (en) 2003-12-02
WO2003096965A3 (fr) 2004-04-22

Similar Documents

Publication Publication Date Title
EP1465615A4 (en) TRICYCLIC BISENONE DERIVATIVES AND METHODS OF USE
ZA200500680B (en) Quinoline derivatives and their use as mycrobacterial inhibitors
PL376566A1 (pl) Pochodne podstawionych 2-alkiloamino-nikotynamidów oraz sposoby wykorzystania
PL375586A1 (en) Substituted anthranilic amide derivatives and methods of use
AU2003284808A8 (en) The derivatives of pyridone and the use of them
EP1474445A4 (en) ADIPONECTIN GLYCO-ISOFORMS, AND USES THEREOF
IL171501A (en) Genetically engineered cutaneous microorganisms and their use
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
HK1079789A1 (zh) 血管靜態毒性試劑及其使用方法
AU2003303128A8 (en) Inhibitors and methods of use thereof
AU2003259735A8 (en) Small-mer compositions and methods of use
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003213606A8 (en) Mp53s as modifiers of the p53 pathway and methods of use
EP1476150A4 (en) CARBOXY FULLERES AND USE METHOD THEREFOR
AU2003299441A8 (en) Nf-hev compositions and methods of use
IL165269A0 (en) Use of quinoline derivatives with anti-integrase effect and applications thereof
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU2003278157A1 (en) Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2003287802A1 (en) Palpometer and methods of use thereof
EP1553101A4 (en) N-acetylglucosamine derivatives and their use
AU2003285686A8 (en) Glycoisoforms of adiponectin and uses thereof
AU2003279800A8 (en) Sulfatases and methods of use thereof